Belharra Therapeutics jobs and careers

About Belharra Therapeutics

Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational state, and in any cell type using its chemoproteomicsplatform. Belharra is based in the San Francisco Bay Area, with its primary lab and offices in San Diego.

Founded in 2021 by Benjamin Cravatt, Christopher Parker, John Teijaro and Stuart Schreiber.